sparteine sulfate

Independent reference data for sparteine sulfate (CAS 6160-12-9), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

• Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
• Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)

Synonyms and trade names

GQ3J2TLZ7E; NSC-755834; RefChem:932007; Pachycarpine Sulfate (1:1), Pentahydrate, (7S-(7alpha,7aalpha,14alpha,14abeta))-; 6160-12-9; Sparteine Sulfate; Sparteine sulfate pentahydrate; Sparteinum sulphuricum; (+)-Sparteine (sulfate pentahydrate); (+)-SPARTEINE SULFATE PENTAHYDRATE; (1R,2S,9R,10R)-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane;sulfuric acid;pentahydrate; CHEMBL2303617; HY-B1304A; DTXSID50977192; AKOS026749948; MS-27422

GHS hazard classification

What the public record says

sparteine sulfate · CAS 6160-12-9 · C15H38N2O9S. UNII GQ3J2TLZ7E.

Source: PubChem / Wikidata; the batch COA governs where values differ.